EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. [electronic resource]
Producer: 20141103Description: 280-6 p. digitalISSN:- 1476-5365
- Adult
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Cohort Studies
- Epstein-Barr Virus Infections -- drug therapy
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunotherapy
- Lymphoproliferative Disorders -- virology
- Male
- Middle Aged
- Prognosis
- Retrospective Studies
- Rituximab
- Survival Analysis
- Transplantation Conditioning -- adverse effects
- Viral Load
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.